Reaction Details Report a problem with these data
Target
Galectin-3
Ligand
BDBM50272301
Substrate
n/a
Meas. Tech.
ChEMBL_510248 (CHEMBL1008161)
IC50
2500000±n/a nM
Citation
 Giguère, D; Bonin, MA; Cloutier, P; Patnam, R; St-Pierre, C; Sato, S; Roy, R Synthesis of stable and selective inhibitors of human galectins-1 and -3. Bioorg Med Chem 16:7811-23 (2008) [PubMed]  Article 
Target
Name:
Galectin-3
Synonyms:
LEG3_HUMAN | LGALS3 | MAC2
Type:
Enzyme
Mol. Mass.:
26156.54
Organism:
Homo sapiens (Human)
Description:
P17931
Residue:
250
Sequence:
MADNFSLHDALSGSGNPNPQGWPGAWGNQPAGAGGYPGASYPGAYPGQAPPGAYPGQAPPGAYPGAPGAYPGAPAPGVYPGPPSGPGAYPSSGQPSATGAYPATGPYGAPAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI
  
Inhibitor
Name:
BDBM50272301
Synonyms:
5-(beta-D-Galactopyranosyl)-4-methyl-2-(2,5-dibromophenyl)sulfonylaminothiazole | CHEMBL499071
Type:
Small organic molecule
Emp. Form.:
C17H20Br2N2O7S2
Mol. Mass.:
588.288
SMILES:
Cc1nc(NS(=O)(=O)c2cc(Br)ccc2Br)sc1C[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O |r|
Structure:
Search PDB for entries with ligand similarity: